These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 24112408)

  • 1. Immunohistochemical localization of spatacsin in α-synucleinopathies.
    Kuru S; Yoshida M; Tatsumi S; Mimuro M
    Neuropathology; 2014 Apr; 34(2):135-9. PubMed ID: 24112408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
    Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T
    Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FBXO7 immunoreactivity in α-synuclein-containing inclusions in Parkinson disease and multiple system atrophy.
    Zhao T; Severijnen LA; van der Weiden M; Zheng PP; Oostra BA; Hukema RK; Willemsen R; Kros JM; Bonifati V
    J Neuropathol Exp Neurol; 2013 Jun; 72(6):482-8. PubMed ID: 23656991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FKBP12-immunopositive inclusions in patients with α-synucleinopathies.
    Honjo Y; Ayaki T; Horibe T; Ito H; Takahashi R; Kawakami K
    Brain Res; 2018 Feb; 1680():39-45. PubMed ID: 29246765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and neuropathological correlates of Lewy body disease.
    Hishikawa N; Hashizume Y; Yoshida M; Sobue G
    Acta Neuropathol; 2003 Apr; 105(4):341-50. PubMed ID: 12624787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of HtrA2/Omi in neuronal and glial inclusions in brains with alpha-synucleinopathies.
    Kawamoto Y; Kobayashi Y; Suzuki Y; Inoue H; Tomimoto H; Akiguchi I; Budka H; Martins LM; Downward J; Takahashi R
    J Neuropathol Exp Neurol; 2008 Oct; 67(10):984-93. PubMed ID: 18800009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein].
    Iwatsubo T
    Rinsho Shinkeigaku; 1999 Dec; 39(12):1285-6. PubMed ID: 10791099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TIGAR inclusion pathology is specific for Lewy body diseases.
    López KLR; Simpson JE; Watson LC; Mortiboys H; Hautbergue GM; Bandmann O; Highley JR
    Brain Res; 2019 Mar; 1706():218-223. PubMed ID: 30267647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagic adapter protein NBR1 is localized in Lewy bodies and glial cytoplasmic inclusions and is involved in aggregate formation in α-synucleinopathy.
    Odagiri S; Tanji K; Mori F; Kakita A; Takahashi H; Wakabayashi K
    Acta Neuropathol; 2012 Aug; 124(2):173-86. PubMed ID: 22484440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropathology underlying clinical variability in patients with synucleinopathies.
    Halliday GM; Holton JL; Revesz T; Dickson DW
    Acta Neuropathol; 2011 Aug; 122(2):187-204. PubMed ID: 21720849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
    Chalmers KA; Love S
    J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accumulation of Hsc70 and Hsp70 in glial cytoplasmic inclusions in patients with multiple system atrophy.
    Kawamoto Y; Akiguchi I; Shirakashi Y; Honjo Y; Tomimoto H; Takahashi R; Budka H
    Brain Res; 2007 Mar; 1136(1):219-27. PubMed ID: 17240362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of CHMP2B-immunoreactivity in the brainstem of Lewy body disease.
    Kurashige T; Takahashi T; Yamazaki Y; Hiji M; Izumi Y; Yamawaki T; Matsumoto M
    Neuropathology; 2013 Jun; 33(3):237-45. PubMed ID: 22989140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silver stainings distinguish Lewy bodies and glial cytoplasmic inclusions: comparison between Gallyas-Braak and Campbell-Switzer methods.
    Uchihara T; Nakamura A; Mochizuki Y; Hayashi M; Orimo S; Isozaki E; Mizutani T
    Acta Neuropathol; 2005 Sep; 110(3):255-60. PubMed ID: 16003542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accumulation of phosphorylated alpha-synuclein in the brain and peripheral ganglia of patients with multiple system atrophy.
    Nishie M; Mori F; Fujiwara H; Hasegawa M; Yoshimoto M; Iwatsubo T; Takahashi H; Wakabayashi K
    Acta Neuropathol; 2004 Apr; 107(4):292-8. PubMed ID: 14722716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding the spectrum of neuronal pathology in multiple system atrophy.
    Cykowski MD; Coon EA; Powell SZ; Jenkins SM; Benarroch EE; Low PA; Schmeichel AM; Parisi JE
    Brain; 2015 Aug; 138(Pt 8):2293-309. PubMed ID: 25981961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical localization of NUB1, a synphilin-1-binding protein, in neurodegenerative disorders.
    Tanji K; Mori F; Kakita A; Zhang H; Kito K; Kamitani T; Takahashi H; Wakabayashi K
    Acta Neuropathol; 2007 Oct; 114(4):365-71. PubMed ID: 17549501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathology and molecular diagnosis of Synucleinopathies.
    Koga S; Sekiya H; Kondru N; Ross OA; Dickson DW
    Mol Neurodegener; 2021 Dec; 16(1):83. PubMed ID: 34922583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylated NUB1 distinguishes α-synuclein in Lewy bodies from that in glial cytoplasmic inclusions in multiple system atrophy.
    Tanji K; Miki Y; Mori F; Kon T; Kakita A; Takahashi H; Wakabayashi K
    Brain Pathol; 2019 Nov; 29(6):803-812. PubMed ID: 31006160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.